Publikationen

2012

Goebel,G., R.Berger, A.M.Strasak, D.Egle, E.Muller-Holzner, S.Schmidt, J.Rainer, E.Presul, W.Parson, S.Lang, A.Jones, M.Widschwendter, and H.Fiegl. 2012. Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients. Br.J.Cancer 106:189-198.

Mansha,M., M.Wasim, A.Kofler, and C.Ploner. 2012. Expression and glucocorticoid-regulation of "Bam", a novel BH3-only transcript in acute lymphoblastic leukemia. Mol.Biol.Rep. in press.

Rainer,J., J.Lelong, D.Bindreither, C.Mantinger, C.Ploner, S.Geley, and R.Kofler. 2012. Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia. Mol.Endocrinol. 26:178-193.

2011

Barisic,M. and S.Geley. 2011. Spindly switch controls anaphase: spindly and RZZ functions in chromosome attachment and mitotic checkpoint control. Cell Cycle 10:449-456.

Eberhart,K., J.Rainer, D.Bindreither, I.Ritter, E.Gnaiger, R.Kofler, P.J.Oefner, and K.Renner. 2011. Glucocorticoid-induced alterations in mitochondrial membrane properties and respiration in childhood acute lymphoblastic leukemia. Biochim.Biophys.Acta 1807:719-725.

Fuka,G., M.Kauer, R.Kofler, O.A.Haas, and R.Panzer-Grumayer. 2011. The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression. PLoS ONE 6:e26348.

Grespi,F., E.Ottina, N.Yannoutsos, S.Geley, and A.Villunger. 2011. Generation and evaluation of an IPTG-regulated version of Vav-gene promoter for mouse transgenesis. PLoS ONE 6:e18051.

Hausmann,M., K.Leucht, C.Ploner, S.Kiessling, A.Villunger, H.Becker, C.Hofmann, W.Falk, M.Krebs, S.Kellermeier, M.Fried, J.Scholmerich, F.Obermeier, and G.Rogler. 2011. BCL-2 Modifying Factor (BMF) Is a Central Regulator of Anoikis in Human Intestinal Epithelial Cells. J.Biol.Chem. 286:26533-26540.

Kuster,L., R.Grausenburger, G.Fuka, U.Kaindl, G.Krapf, A.Inthal, G.Mann, M.Kauer, J.Rainer, R.Kofler, A.Hall, M.Metzler, L.H.Meyer, C.Meyer, J.Harbott, R.Marschalek, S.Strehl, O.A.Haas, and R.Panzer-Grumayer. 2011. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling. Blood 117:2658-2667.

Mikolcevic,P., R.Sigl, V.Rauch, M.W.Hess, K.Pfaller, M.Barisic, L.J.Pelliniemi, M.Boesl, and S.Geley. 2011. CDK16/PCTAIRE kinase 1 is activated by Cyclin Y and is essential for spermatogenesis. Mol.Cell Biol. in press.

Oppl,B., A.Kofler, S.Schwarz, J.Rainer, and R.Kofler. 2011. Establishing a sensitive and specific assay for determination of glucocorticoid bioactivity. Wien.Klin.Wochenschr. 123:222-229.

Prokudin,I., T.Stasyk, J.Rainer, G.K.Bonn, R.Kofler, and L.A.Huber. 2011. Comprehensive proteomic and transcriptomic characterization of hepatic expression signatures affected in p14 liver conditional knockout mice. Proteomics. 11:469-480.

Sanchez-Cabo,F., J.Rainer, A.Dopazo, Z.Trajanoski, and H.Hackl. 2011. Insights into global mechanisms and disease by gene expression profiling. In Bioinformatics for Omics Data. B.Mayer, editor. Humana Press, New York. 269-298.

2010

Aryee,D.N., S.Niedan, M.Kauer, R.Schwentner, I.M.nani-Baiti, J.Ban, K.Muehlbacher, M.Kreppel, R.L.Walker, P.Meltzer, C.Poremba, R.Kofler, and H.Kovar. 2010. Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro. Cancer Res. 70:4015-4023.

Barisic,M., B.Sohm, P.Mikolcevic, C.Wandke, V.Rauch, T.Ringer, M.Hess, G.Bonn, and S.Geley. 2010. Spindly/CCDC99 Is Required for Efficient Chromosome Congression and Mitotic Checkpoint Regulation. Mol.Biol.Cell 21:1968-1981.

Carlet,M., K.Janjetovic, J.Rainer, S.Schmidt, R.Panzer-Grumayer, G.Mann, M.Prelog, B.Meister, C.Ploner, and R.Kofler. 2010. Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells. BMC.Cancer 10:638.

Frenzel,A., V.Labi, W.Chmelewskij, C.Ploner, S.Geley, H.Fiegl, A.Tzankov, and A.Villunger. 2010. Suppression of B cell lymphomagenesis by the BH3-only proteins Bmf and Bad. Blood 115:995-1005.

Grespi,F., C.Soratroi, G.Krumschnabel, B.Sohm, C.Ploner, S.Geley, L.Hengst, G.Hacker, and A.Villunger. 2010. BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis. Cell Death.Differ. 17:1672-1683.

Mansha,M., M.Carlet, C.Ploner, G.Gruber, M.Wasim, G.J.Wiegers, J.Rainer, S.Geley, and R.Kofler. 2010. Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia. Leuk.Res. 34:529-534.

Wasim,M., M.Mansha, M.Carlet, R.Greil, C.Ploner, A.Trockenbacher, J.Rainer, and R.Kofler. 2010. PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis. J.Steroid Biochem.Mol.Biol. 120:218-227.

2009

Eberhart,K., K.Renner, I.Ritter, M.Kastenberger, K.Singer, C.Hellerbrand, M.Kreutz, R.Kofler, and P.J.Oefner. 2009. Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis. Leukemia 23:2167-2170.

Ecker,K., A.Lorenz, F.Wolf, C.Ploner, G.Böck, T.Duncan, S.Geley, and A.Helmberg. 2009. A ras recruitment screen identifies ZKSCAN4 as a glucocorticoid receptor-interacting protein. J.Mol.Endocrinol. 42:105-117.

Gruber,G., M.Carlet, E.Turtscher, B.Meister, J.A.Irving, C.Ploner, and R.Kofler. 2009. Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis. Leukemia 23:820-823.

Kauer,M., J.Ban, R.Kofler, B.Walker, S.Davis, P.Meltzer, and H.Kovar. 2009. A molecular function map of Ewing´s sarcoma. PLoS ONE 4:e5415.

Obexer,P., J.Hagenbuchner, M.Rupp, C.Salvador, M.Holzner, M.Deutsch, V.Porto, R.Kofler, T.Unterkirchner, and M.J.Ausserlechner. 2009. p16INK4A sensitizes human leukemia cells to FAS- and glucocorticoid-induced apoptosis via induction of BBC3/Puma and repression of MCL1 and BCL2. J.Biol.Chem. 284:30933-30940.

Ploner,A., C.Ploner, M.Lukasser, H.Niederegger, and A.Huttenhofer. 2009. Methodological obstacles in knocking down small noncoding RNAs. RNA. 15:1797-1804.

Ploner,C., J.Rainer, S.Lobenwein, S.Geley, and R.Kofler. 2009. Repression of the BH3-only molecule PMAIP1/Noxa impairs glucocorticoid sensitivity of acute lymphoblastic leukemia cells. Apoptosis 14:821-828.

Rainer,J., C.Ploner, S.Jesacher, A.Ploner, M.Eduardoff, M.Mansha, M.Wasim, R.Panzer-Grümayer, Z.Trajanoski, H.Niederegger, and R.Kofler. 2009. Glucocorticoid regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia 23:746-752.

Sigl,R., C.Wandke, V.Rauch, J.Kirk, T.Hunt, and S.Geley. 2009. Loss of the mammalian APC/C activator FZR1 shortens G1 and lengthens S phase but has little effect on exit from mitosis. J.Cell Sci. 122:4208-4217.

Weber,A., Z.Kirejczyk, S.Potthoff, C.Ploner, and G.Hacker. 2009. Endogenous Noxa Determines the Strong Proapoptotic Synergism of the BH3-Mimetic ABT-737 with Chemotherapeutic Agents in Human Melanoma Cells. Transl.Oncol. 2:73-83.

2008

Ploner,C., R.Kofler, and A.Villunger. 2008. Noxa: at the tip of the balance between live and death. Oncogene 27 Suppl 1:S84-S92.

Ploner,C., J.Rainer, H.Niederegger, M.Eduardoff, A.Villunger, S.Geley, and R.Kofler. 2008. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 22:370-377.

2007

Jurgeit,A., C.Berlato, P.Obrist, C.Ploner, P.Massoner, J.Schmolzer, M.C.Haffner, H.Klocker, L.A.Huber, S.Geley, and W.Doppler. 2007. Insulin-like growth factor binding protein (IGFBP)-5 enters vesicular structures but not the nucleus. Traffic 8:1815-1828.

Presul,E., S.Schmidt, R.Kofler, and A.Helmberg. 2007. Identification, tissue specific expression and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. J.Mol.Endocrinol. 38:79-90.

Wolf,F., R.Sigl, and S.Geley. 2007. '... The End of the Beginning': Cdk1 Thresholds and Exit from Mitosis. Cell Cycle 6:1408-1411.

2006

Ausserlechner,M.J., P.Obexer, A.Deutschmann, K.Geiger, and R.Kofler. 2006. A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes. Mol.Cancer Ther. 5:1927-1934.

Bacher,N., M.Tiefenthaler, S.Sturm, H.Stuppner, M.J.Ausserlechner, R.Kofler, and G.Konwalinka. 2006. Oxinddole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2 expressing acute lymphoblastic leukaemia cells. Br.J.Haematol. 132:615-622.

Kreppel,M., D.N.T.Aryee, K.L.Schaefer, G.Amann, R.Kofler, C.Poremba, and H.Kovar. 2006. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migration ability of Ewing´s sarcoma cells. Oncogene 25:2795-2800.

Schmidt,S., J.A.Irving, L.Minto, E.Matheson, L.Nicholson, A.Ploner, W.Parson, A.Kofler, M.Amort, M.Erdel, A.Hall, and R.Kofler. 2006. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB J.  20:2600-2602.

Schmidt,S., J.Rainer, S.Riml, C.Ploner, S.Jesacher, C.Achmüller, E.Presul, S.Skvortsov, R.Crazzolara, M.Fiegl, T.Raivio, O.A.Jänne, S.Geley, B.Meister, and R.Kofler. 2006. Identification of glucocorticoid response genes in children with acute lymphoblastic leukemia. Blood 107:2061-2069.

Stadlmann,S., K.Renner, J.Pollheimer, P.L.Moser, A.G.Zeimet, F.A.Offner, and E.Gnaiger. 2006. Preserved Coupling of Oxidative Phosphorylation But Decreased Mitochondrial Respiratory Capacity in IL-1beta-Treated Human Peritoneal Mesothelial Cells. Cell Biochem.Biophys. 44:179-186.

Stadlmann,S., J.Pollheimer, K.Renner, A.G.Zeimet, F.A.Offner, and A.Amberger. 2006. Response of human peritoneal mesothelial cells to inflammatory injury is regulated by interleukin-1beta and tumor necrosis factor-alpha. Wound.Repair Regen. 14:187-194.

Wandke,C. and S.Geley. 2006. Generation and characterization of an hKid-specific monoclonal antibody. Hybridoma (Larchmt.) 25:41-43.

Wolf,F., C.Wandke, N.Isenberg, and S.Geley. 2006. Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. EMBO J. 25:2802-2813.

2005

Ausserlechner,M.J., P.Obexer, S.Geley, and R.Kofler. 2005. G1 arrest by P16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-myc expression. Leukemia 19:1051-1057.

Parson,W., R.Kirchebner, R.Mühlmann, K.Renner, A.Kofler, S.Schmidt, and R.Kofler. 2005. Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J. 19:434-436.

Ploner,C., S.Schmidt, E.Presul, K.Renner, K.Schröcksnadel, J.Rainer, S.Riml, and R.Kofler. 2005. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J.Steroid Biochem.Mol.Biol. 93:153-160.

Tzankov,A., A.Zimpfer, P.Went, R.Maurer, S.A.Pileri, S.Geley, and S.Dirnhofer. 2005. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma. Mod.Pathol. 18:90-96.

2004

Ausserlechner,M.J., P.Obexer, G.Böck, S.Geley, and R.Kofler. 2004. Cyclin D3 and c-myc control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells. Cell Death.Differ. 11:165-174.

Geley,S. and C.Muller. 2004. RNAi: ancient mechanism with a promising future. Exp.Gerontol. 39:985-998.

Hutter,E., K.Renner, G.Pfister, P.Stockl, P.Jansen-Durr, and E.Gnaiger. 2004. Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem.J. 380:919-928.

Riml,S., S.Schmidt, M.J.Ausserlechner, S.Geley, and R.Kofler. 2004. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death.Differ. 11 Suppl 1:S65-S72.

Schmidt,S., J.Rainer, C.Ploner, E.Presul, S.Riml, and R.Kofler. 2004. Glucocorticoid-induced apoptosis and glucocorticoid resistance: Molecular mechanisms and clinical relevance. Cell Death.Differ. 11 Suppl 1:S45-S55.

Tsurumi,C., S.Hoffmann, S.Geley, R.Graeser, and Z.Polanski. 2004. The spindle assembly checkpoint is not essential for CSF arrest of mouse oocytes. J.Cell Biol. 167:1037-1050.

 

2003

Larcher,C., D.Bernhard, E.Schaadt, B.Adler, M.J.Ausserlechner, M.Mitterer, and H.P.Huemer. 2003. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants. Haematologica 88:1324-1335.

Kofler,R., S.Schmidt, A.Kofler, and M.J.Ausserlechner. 2003. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J. Endocrinol. 178:19-27.

Bernhard,D., W.Schwaiger, R.Crazzolara, I.Tinhofer, R.Kofler, and A.Csordas. 2003. Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett. 195:193-199.

Villunger,A., E.M.Michalak, L.Coultas, F.Mullauer, G.Bock, M.J.Ausserlechner, J.M.Adams, and A.Strasser. 2003. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036-1038.

Tzankov,A., A.Zimpfer, A.Lugli, J.Krugmann, P.Went, P.Schraml, R.Maurer, S.Ascani, S.Pileri, S.Geley, and S.Dirnhofer. 2003. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1. J. Pathol. 199:201-207.

Renner,K., M.J.Ausserlechner, and R.Kofler. 2003. A conceptual view on glucocorticoid-induced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia. Curr. Mol. Med. 3:707-717.

2002

Tonko-Geymayer,S., O.Goupille, M.Tonko, C.Soratroi, A.Yoshimura, C.Streuli, A.Ziemiecki, R.Kofler, and W.Doppler. 2002. Regulation and function of the cytokine inducible SH-2 domain proteins cis and socs3 in mammary epithelial cells. Mol. Endocrinol. 16:1680-1695.

Ruefli,A.A., D.Bernhard, K.Tainton, R.Kofler, M.J.Smyth, and R.W.Johnstone. 2002. Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-gp expressing cells. Int. J. Cancer 99:292-298.

Crazzolara,R., K.Jöhrer, R.W.Johnstone, R.Greil, R.Kofler, B.Meister, and D.Bernhard. 2002. Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukemia. Br. J. Haematol. 119:965-969.

2001

Tonko,M., M.J.Ausserlechner, D.Bernhard, A.Helmberg, and R.Kofler. 2001. Gene expression profiles of proliferating versus G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J. 15:693-699.

Tinhofer,I., D.Bernhard, M.Senfter, G.Anether, M.Loeffler, G.Kroemer, R.Kofler, A.Csordas, and R.Greil. 2001. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 9:1613-1615.

Tiefenthaler,M., A.Amberger, N.Bacher, B.L.Hartmann, R.Margreiter, R.Kofler, and G.Konwalinka. 2001. Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells. Br. J. Haematol. 114:574-580.

Ruefli,A.A., M.J.Ausserlechner, D.Bernhard, V.R.Sutton, K.M.Tainton, R.Kofler, M.J.Smyth, and R.W.Johnstone. 2001. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 98:10833-10838.

Pallis,M., M.Grundy, J.Turzanski, R.Kofler, and N.Russel. 2001. Mitochondrial membrane sensitivity to depolarization in acute myeloblastic leukaemia is associated with spontaneous in vitro apoptosis, wild-type TP53 and vicinal thiol/disulphide status. Blood 98:405-413.

Obexer,P., U.Certa, R.Kofler, and A.Helmberg. 2001. Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis. Oncogene 20:4324-4336.

Helmberg,A. 2001. DNA-microarrays: novel techniques to study aging and guide gerontologic medicine. Exp. Gerontol. 36:1189-1198.

Bernhard,D., S.Skvortsov, I.Tinhofer, H.Hübl, R.Greil, A.Csordas, and R.Kofler. 2001. Inhibition of histone deacetylase activity enhances fas-induced apoptosis in leukemic lymphoblasts. Cell Death Differ. 8:1014-1021.

Wagner,M., B.Hampel, D.Bernhard, M.Hala, W.Zwerschke, and P.Jansen-Durr. 2001. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp. Gerontol. 36:1327-1347.

Ausserlechner,M.J., P.Obexer, G.J.Wiegers, B.L.Hartmann, S.Geley, and R.Kofler. 2001. The cell cycle inhibitor p16/INK4A sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels. J. Biol. Chem. 276:10984-10989.

2000

Kuhr,T., O.Bechter, S.Dirnhofer, S.Geley, A.Gachter, G.Pall, M.Url, H.Dietrich, P.Oberaigner, G.Klima, W.Eisterer, W.Hilbe, P.Lukas, and J.Thaler. 2000. Transplantation of IL-2-transduced murine bone marrow is associated with dose-dependent toxicity. Exp. Hematol. 28:895-906.

Bernhard,D., I.Tinhofer, M.Tonko, H.Hübl, M.J.Ausserlechner, R.Greil, R.Kofler, and A.Csordas. 2000. Resveratrol causes arrest in the S-phase prior to fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 7:834-842.

Kofler,R. 2000. The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochem. Cell Biol. 114:1
-7.